Skip to main content
. 2014 Jul-Aug;40(4):373–379. doi: 10.1590/S1806-37132014000400004

Figure 2. Relative serum von Willebrand factor (vWF) activity. In A, comparison between the smoker and COPD groups. In B, comparison between the symptomatic COPD and mildly symptomatic/asymptomatic COPD subgroups as defined by the modified Medical Research Council (mMRC) scale scores.

Figure 2